[Remote glycemic control using devices for wireless data transmission in children with type 1 diabetes mellitus: interim results of clinical approbation].

D N Laptev, A O Emelyanov, E S Demina, I L Nikitina, G A Galkina, A A Voropay, E S Malysheva, Yu G Samoylova, V A Peterkova
{"title":"[Remote glycemic control using devices for wireless data transmission in children with type 1 diabetes mellitus: interim results of clinical approbation].","authors":"D N Laptev, A O Emelyanov, E S Demina, I L Nikitina, G A Galkina, A A Voropay, E S Malysheva, Yu G Samoylova, V A Peterkova","doi":"10.14341/probl13492","DOIUrl":null,"url":null,"abstract":"<p><p>Despite marked improvements in glycemic control in recent years, many patients with type 1 diabetes mellitus (T1DM) do not achieve glycated hemoglobin (HbA1c) targets.Considering the need for regular interaction between a doctor and a patient with T1DM, and taking into account the geographical features of the Russian Federation, the use of telemedicine can help improve the effectiveness of treatment.</p><p><strong>Objective: </strong> To evaluate the clinical effectiveness of remote glycemic control using devices for wireless data transmission in children with type 1 diabetes mellitus.</p><p><strong>Materials and methods: </strong> Inclusion criteria: Age from 1 to 18 years, diagnosis of T1DM, intensive insulin therapy (through multiple insulin injections or continuous subcutaneous insulin infusion). The duration of the study was 12 months, during which each participant had at least 5 face-to-face consultations and at least 8 remote consultations. Remote monitoring was performed using the OneTouch Reveal (OT Reveal) mobile application.</p><p><strong>Results: </strong> A total of 58 patients with T1DM aged 1 to 18 years were included in the study. The HbA1c level during the study period decreased from 7.6% [7.0; 8.7] at baseline to 7.2% [6.5; 8.2] by the end of the study, after 12 months of follow-up (p=0.025). It should be noted that the best glycemic control was observed after 3 months of observation (HbA1c -7.2% [6.5; 8.5], number of children with HbA1c&lt;7.0% - 44% (31-59)). The median % of measurements in the target range from 3.9 to 10.0 mmol/L increased from 51.1% [38.9; 63.6] at baseline to 59.6% [46.9; 69.8] (p=0.03).</p><p><strong>Conclusion: </strong> Using a glucose meter in combination with diabetes management software and remote data transfer capabilities is associated with significant improvements in glycemic control in children with T1DM. Further results of clinical testing will allow a more detailed assessment of the effectiveness of this approach, but it can already be said that wider use of these opportunities may improve the availability of medical care and achieve better compensation for many patients with T1DM.</p>","PeriodicalId":101419,"journal":{"name":"Problemy endokrinologii","volume":"71 3","pages":"39-45"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12319630/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Problemy endokrinologii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14341/probl13492","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Despite marked improvements in glycemic control in recent years, many patients with type 1 diabetes mellitus (T1DM) do not achieve glycated hemoglobin (HbA1c) targets.Considering the need for regular interaction between a doctor and a patient with T1DM, and taking into account the geographical features of the Russian Federation, the use of telemedicine can help improve the effectiveness of treatment.

Objective:  To evaluate the clinical effectiveness of remote glycemic control using devices for wireless data transmission in children with type 1 diabetes mellitus.

Materials and methods:  Inclusion criteria: Age from 1 to 18 years, diagnosis of T1DM, intensive insulin therapy (through multiple insulin injections or continuous subcutaneous insulin infusion). The duration of the study was 12 months, during which each participant had at least 5 face-to-face consultations and at least 8 remote consultations. Remote monitoring was performed using the OneTouch Reveal (OT Reveal) mobile application.

Results:  A total of 58 patients with T1DM aged 1 to 18 years were included in the study. The HbA1c level during the study period decreased from 7.6% [7.0; 8.7] at baseline to 7.2% [6.5; 8.2] by the end of the study, after 12 months of follow-up (p=0.025). It should be noted that the best glycemic control was observed after 3 months of observation (HbA1c -7.2% [6.5; 8.5], number of children with HbA1c<7.0% - 44% (31-59)). The median % of measurements in the target range from 3.9 to 10.0 mmol/L increased from 51.1% [38.9; 63.6] at baseline to 59.6% [46.9; 69.8] (p=0.03).

Conclusion:  Using a glucose meter in combination with diabetes management software and remote data transfer capabilities is associated with significant improvements in glycemic control in children with T1DM. Further results of clinical testing will allow a more detailed assessment of the effectiveness of this approach, but it can already be said that wider use of these opportunities may improve the availability of medical care and achieve better compensation for many patients with T1DM.

Abstract Image

Abstract Image

[使用无线数据传输设备对1型糖尿病儿童进行远程血糖控制:临床批准的中期结果]。
尽管近年来血糖控制有明显改善,但许多1型糖尿病(T1DM)患者并没有达到糖化血红蛋白(HbA1c)的目标。考虑到医生与T1DM患者之间需要定期互动,并考虑到俄罗斯联邦的地理特征,使用远程医疗有助于提高治疗效果。目的:探讨应用无线数据传输装置进行1型糖尿病儿童远程血糖控制的临床效果。材料与方法:纳入标准:年龄1 ~ 18岁,诊断为T1DM,胰岛素强化治疗(多次注射胰岛素或持续皮下注射胰岛素)。研究为期12个月,在此期间每位参与者至少进行了5次面对面咨询和至少8次远程咨询。使用OneTouch Reveal (OT Reveal)移动应用程序进行远程监测。结果:共纳入58例1 ~ 18岁T1DM患者。研究期间HbA1c水平从7.6% [7.0;基线为8.7%至7.2% [6.5%;8.2]在研究结束时,经过12个月的随访(p=0.025)。值得注意的是,观察3个月后血糖控制效果最佳(HbA1c -7.2% [6.5;[8.5], hba1c的儿童人数为7.0% - 44%(31-59))。在3.9 ~ 10.0 mmol/L目标范围内测量的中位数百分比从51.1% [38.9;63.6]至59.6% [46.9];69.8 (p = 0.03)。结论:结合糖尿病管理软件和远程数据传输功能使用血糖仪可显著改善T1DM患儿的血糖控制。临床试验的进一步结果将允许对这种方法的有效性进行更详细的评估,但已经可以说,更广泛地利用这些机会可能会改善医疗保健的可得性,并为许多T1DM患者提供更好的补偿。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信